França Roberta, Cordeiro Adryana, Pereira Silvia Elaine, Saboya Carlos José, Ramalho Andrea
Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-598, Brazil.
Micronutrients Research Center (NPqM), Institute of Nutrition, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil.
Metabolites. 2023 Apr 27;13(5):603. doi: 10.3390/metabo13050603.
Vitamin D status affects the clinical and corporal outcomes of postoperative patients who undergo a Roux-en-Y gastric bypass (RYGB). The aim of this study was to evaluate the effect of adequate vitamin D serum concentrations on thyroid hormones, body weight, blood cell count, and inflammation after an RYGB. A prospective observational study was conducted with eighty-eight patients from whom we collected blood samples before and 6 months after surgery to evaluate their levels of 25-hydroxyvitamin D 25(OH)D, thyroid hormones, and their blood cell count. Their body weight, body mass index (BMI), total weight loss, and excess weight loss were also evaluated 6 and 12 months after surgery. After 6 months, 58% of the patients achieved an adequate vitamin D nutritional status. Patients in the adequate group showed a decrease in the concentration of thyroid-stimulating hormone (TSH) (3.01 vs. 2.22 µUI/mL, = 0.017) with lower concentrations than the inadequate group at 6 months (2.22 vs. 2.84 µUI/mL, = 0.020). Six months after surgery, the group with vitamin D adequacy showed a significantly lower BMI compared with the inadequate group at 12 months (31.51 vs. 35.04 kg/m, = 0.018). An adequate vitamin D nutritional status seems to favor a significant improvement in one's thyroid hormone levels, immune inflammatory profile, and weight loss performance after an RYGB.
维生素D状态会影响接受Roux-en-Y胃旁路术(RYGB)的术后患者的临床和身体状况。本研究的目的是评估充足的维生素D血清浓度对RYGB术后甲状腺激素、体重、血细胞计数和炎症的影响。对88例患者进行了一项前瞻性观察研究,在手术前和术后6个月采集他们的血样,以评估他们的25-羟基维生素D[25(OH)D]水平、甲状腺激素水平和血细胞计数。在术后6个月和12个月还评估了他们的体重、体重指数(BMI)、总体重减轻和超重减轻情况。6个月后,58%的患者达到了充足的维生素D营养状态。充足组患者的促甲状腺激素(TSH)浓度降低(3.01 vs. 2.22 μUI/mL,P = 0.017),且在6个月时浓度低于不足组(2.22 vs. 2.84 μUI/mL,P = 0.020)。术后6个月,维生素D充足组的BMI在12个月时显著低于不足组(31.51 vs. 35.04 kg/m²,P = 0.018)。充足的维生素D营养状态似乎有利于RYGB术后患者甲状腺激素水平、免疫炎症指标和体重减轻表现的显著改善。